A significant discovery in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently lost in many types of tumors, causing https://rankuppages.com/story7011880/mini-antibodies-revive-the-p53-protein-a-potential-pathway-for-malignant-therapy